Fingerprint
Dive into the research topics of 'Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically